SCRI Oncology Partners Group — Nashville, Tennessee

SCRI Oncology Partners Group is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

SCRI Oncology Partners Group has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Advanced Breast Cancer.

Sponsors: Stemline Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SCRI Oncology Partners Group?

SCRI Oncology Partners Group has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SCRI Oncology Partners Group conducted?

SCRI Oncology Partners Group has 1 clinical trials on record, with 1 currently active. Their work covers Advanced Breast Cancer.

Is SCRI Oncology Partners Group accredited by Crixeo Health?

SCRI Oncology Partners Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SCRI Oncology Partners Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.